Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 37406

Original article / research
Year : 2018 | Month : June | Volume : 12 | Issue : 6 | Page : DC37 - DC41

Antimycobacterial Activities of an Edible Mushroom Extract and its Synergy with the Standard Antituberculous Drugs

Debasmita Chatterjee, Dipankar Halder, Urmita Chakraborty, Devarati Dutta, Satadal Das

1. Research Fellow, Department of Food Technology and Biochemical Engineering, Jadavpur University, Kolkata, West Bengal, India. 2. Associate Professor, Department of Food Technology and Biochemical Engineering, Jadavpur University, Kolkata, West Bengal, India. 3. Research Associate, Department of Virology, DAC Regional Research Institute, CCRH, Kolkata, West Bengal, India. 4. Research Fellow, Department of Microbiology, Peerless Hospital and B. K. Roy Research Centre, Kolkata, West Bengal, India. 5. Principal Investigator, Department of Microbiology, Peerless Hospital and B. K. Roy Research Centre, Kolkata, West Bengal, India.

Correspondence Address :
Dr. Satadal Das,
Principal Investigator, Department of Microbiology, Peerless Hospital and B. K. Roy Research Centre,
Kolkata-700094, West Bengal, India.
E-mail: drsatdas@hotmail.com

Abstract

Introduction: Tuberculosis is a leading cause of death in most developing countries mainly due to drug resistance. Mushrooms are reservoirs of many unexplored active ingredients in relation to antimicrobial applications, giving us a scope to exploit it to see whether antituberculosis activity is pertaining with it.

Aim: We explored one member of edible mushroom Pleurotus ostreatus for its antimycobacterial activities.

Materials and Methods: Minimum Inhibitory Concentration (MIC) of the mushroom extract was assayed against Mycobacterial strains-H37Ra, 2 clinical Mycobacterium tuberculosis isolates and one MOTT (Mycobacterium Other Than Tuberculosis). Haemotoxicity analysis and characterisation of bioactive ingredients of extract were also studied. Synergistic study with Ethambutol (EMB), Isoniazid (INH) and Rifampicin (RIF) was also done.

Results: Ethanolic extract of mushroom showed MIC values in the range of 2.5 mg/mL-15 mg/mL against the strains collected. No haemotoxicity was found by the bioactive components of the extract upto a concentration of 20 mg/mL. Specific phenol and flavonoid compounds are attributed to the antimycobacterial activity shown by the extract. Excellent synergy of the extract was revealed with RIF followed by EMB against the strains of Mycobacteria, while INH only show synergy against the MOTT.

Conclusion: Mushrooms can be considered as a potent source of bioactive compounds showing antituberculosis activity.

Keywords

Ethambutol, Isoniazid, Mycobacterium tuberculosis, Pleurotus ostreatus, Rifampicin, Synergy

How to cite this article :

Debasmita Chatterjee, Dipankar Halder, Urmita Chakraborty, Devarati Dutta, Satadal Das. ANTIMYCOBACTERIAL ACTIVITIES OF AN EDIBLE MUSHROOM EXTRACT AND ITS SYNERGY WITH THE STANDARD ANTITUBERCULOUS DRUGS. Journal of Clinical and Diagnostic Research [serial online] 2018 June [cited: 2018 Jun 24 ]; 12:DC37-DC41. Available from
http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2018&month=June&volume=12&issue=6&page=DC37-DC41&id=11640

DOI and Others

DOI: 10.7860/JCDR/2018/35569.11640

Date of Submission: Jan 14, 2018
Date of Peer Review: Mar 20, 2018
Date of Acceptance: Apr 28, 2018
Date of Publishing: Jun 01, 2018

FINANCIAL OR OTHER COMPETING INTERESTS: As declared above.

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2016: 132.37
  • SCOPUS
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhost
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com